Acurion, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Acurion, Inc. - overview
Established
2021
Location
San Diego, CA, US
Primary Industry
Healthcare IT
About
Established in 2021, and based in California, US, Acurion, Inc. operates as a oncology company that offer its clients OncoGaze™ AI platform to detect cancer biomarkers, specifically Homologous Recombination Deficiency (HRD), from routine pathology slides.
Current Investors
Mesa Verde Venture Partners, National Foundation for Cancer Research, Bootstrap Ventures
Primary Industry
Healthcare IT
Sub Industries
Healthcare IT, Oncology/Cancer Treatment
Website
www.acurionhealth.com
Verticals
Artificial Intelligence, HealthTech
Company Stage
Angel & Seed
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.